Woolworths Limited is a business in transition: But is it headed up, or down?

Analysts can't seem to agree on the value of Woolworths Limited (ASX:WOW), with estimates varying from as low as $19, to as high as $40.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What is Woolworths Limited (ASX: WOW) really worth?

That depends on your view of the underlying business, naturally. If you thought Woolworths was set to bounce back and rise higher as sales growth commences, then today's prices of $24.82 are cheap.

On the other hand, if you think the company has an uphill battle ahead, today's prices could prove to be quite expensive, despite the company's 29% fall in value over the past year.

It's the kind of 'what-if' scenario stock market investors face every day, but price estimates coming out from industry analysts show that the experts are divided on the topic as well.

According to reports by Fairfax media, Merrill Lynch analyst David Errington has a 'Buy' recommendation and a target price of $40 on the stock.

Morgan Stanley analyst Tom Kierath has a 'Sell' rating, and a target price of $19.

Which is it?

To my mind, this decision calls for a look at Woolworths through a slightly different lens. Woolies is the biggest supermarket in Australia with highly convenient stores and a generally great range of products that consumers love.

The only way for it to lose business is for customers to buy less, or shop elsewhere.

Ergo, Woolworths must be doing something wrong, or competitors Wesfarmers Ltd (ASX: WES), Aldi are doing something better.

If you look at a list of complaints levelled against Woolworths' supermarkets, they often read something like this:

Poor variety/freshness of produce, low shelf stock, tired stores, higher prices, fewer new and innovative products. Complaints against its Masters' hardware chain are similar. Several shareholders have also opined that businesses like Big W are a drag on earnings.

Recent statements from Woolworths show that the company is aware of the problems and it is making numerous changes to stop the loss of market share, including lifting staff hours, refurbishing stores, changing store formats, adjusting the type of products held for different demographics, and so on.

Once the major problems are rectified, unsatisfied customers will probably return.

The busy nature of life in the cities dictates that time-strapped consumers will inevitably pop into their most convenient store occasionally for necessities. Consumers can be slow to change their preferences but they know where they have the best experience, and I wouldn't be surprised to see Woolworths return to at least stagnant sales in the near future.

This is key to the 'Buy' thesis of Merrill Lynch's analyst quoted above, who expects soft same-store sales growth to drive share prices.

However, that doesn't mean that Woolworths is a great buy today.

Cutting prices to drive volume and make items more affordable is likely to impact profit margins, and this combined with heavy capital investment is why Morgan Stanley's analyst expects shares to fall.

I subscribe to both views, and believe that the end result is likely to be somewhere in the middle of both price targets. Woolworths is a great company, with a solid dividend and reasonable prospects and I would be perfectly happy to hold it in my portfolio right now.

However, as a result of it being a business in transition I don't yet feel that it is an outstanding value purchase.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »